ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 65 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,000 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | +25.0% | 1 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q2 2020 | $49,892,000 | +140.4% | 19,489 | +171.4% | 0.00% | – |
| Q1 2020 | $20,756,000 | -3.0% | 7,182 | +27.2% | 0.00% | – |
| Q4 2019 | $21,406,000 | +15.9% | 5,648 | +56.4% | 0.00% | – |
| Q3 2019 | $18,470,000 | +18.6% | 3,611 | +43.8% | 0.00% | – |
| Q2 2019 | $15,568,000 | -53.0% | 2,511 | -46.1% | 0.00% | – |
| Q1 2019 | $33,111,000 | +132.0% | 4,657 | +553.2% | 0.00% | – |
| Q3 2018 | $14,274,000 | -22.5% | 713 | 0.0% | 0.00% | – |
| Q2 2018 | $18,417,000 | -78.8% | 713 | -80.4% | 0.00% | – |
| Q1 2018 | $86,733,000 | -19.4% | 3,629 | +14.2% | 0.00% | – |
| Q4 2017 | $107,669,000 | +204.0% | 3,177 | +89.9% | 0.00% | – |
| Q3 2017 | $35,417,000 | +13.3% | 1,673 | -6.4% | 0.00% | – |
| Q2 2017 | $31,255,000 | +5656.0% | 1,787 | +5664.5% | 0.00% | – |
| Q1 2017 | $543,000 | -88.5% | 31 | -88.9% | 0.00% | – |
| Q4 2016 | $4,732,000 | -75.4% | 280 | -76.1% | 0.00% | – |
| Q3 2016 | $19,249,000 | +94.7% | 1,173 | +79.6% | 0.00% | – |
| Q2 2016 | $9,886,000 | -82.9% | 653 | -68.1% | 0.00% | – |
| Q4 2015 | $57,942,000 | +67.9% | 2,046 | -0.7% | 0.00% | – |
| Q3 2015 | $34,501,000 | +52.1% | 2,061 | +138.3% | 0.00% | – |
| Q2 2015 | $22,680,000 | +1752.9% | 865 | +1135.7% | 0.00% | – |
| Q1 2015 | $1,224,000 | -28.5% | 70 | -23.9% | 0.00% | – |
| Q3 2014 | $1,713,000 | – | 92 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|